APA

Sarganas G., Orzechowski H. D., Klimpel A., Thomae M., Kauffmann W., Herbst H., Bronder E. & Garbe E. (20120829). Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. : Neuro-oncology.

Chicago

Sarganas Giselle, Orzechowski Hans D, Klimpel Andreas, Thomae Michael, Kauffmann Wolfgang, Herbst Hermann, Bronder Elisabeth and Garbe Edeltraut. 20120829. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. : Neuro-oncology.

Harvard

Sarganas G., Orzechowski H. D., Klimpel A., Thomae M., Kauffmann W., Herbst H., Bronder E. and Garbe E. (20120829). Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. : Neuro-oncology.

MLA

Sarganas Giselle, Orzechowski Hans D, Klimpel Andreas, Thomae Michael, Kauffmann Wolfgang, Herbst Hermann, Bronder Elisabeth and Garbe Edeltraut. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. : Neuro-oncology. 20120829.